Sort
40,608 grants matching “prostate cancer”
NOVEL THERAPEUTIC TARGETS IN NEUROENDOCRINE PROSTATE CANCER
$1,170,000Thomas Jefferson University · · FY2022 · Defense Health Agency
TARGETING N-CADHERIN FOR INHIBITION OF ENZALUTAMIDE RESISTANCE AND EMERGENCE OF NEUROENDOCRINE PROSTATE CANCER
$1,170,000University Of California, Los Angeles · · FY2022 · Department of the Army
THE ROLE OF GENOMIC DIVERSITY IN CLINICALLY HIGH-RISK PROSTATE CANCER
$1,169,966University Of California, Los Angeles · · FY2022 · Department of the Army
TARGETING LSD1 IN NEUROENDOCRINE PROSTATE CANCER
$1,169,961Regents Of The University Of Michigan · · FY2020 · Defense Health Agency
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$1,169,903Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Rotating PET and linear accelerator system for PET-guided radiation therapy
$1,169,548Samuel Mazin · Reflexion Medical, Inc. · R44 · FY2014 · CA
TARGETING PROSTATE CANCER STEMLIKE CELLS THROUGH CELL SURFACE-EXPRESSED GRP78
$1,169,544Cold Spring Harbor Laboratory · · FY2012 · Department of the Army
ANALYSIS OF TISSUE ARCHITECTURE TO IDENTIFY LETHAL PROSTATE CANCER IN THE VETERAN POPULATION.
$1,169,247University Of Utah · · FY2021 · Defense Health Agency
INTRATUMORAL HETEROGENEITY OF AGGRESSIVE MOLECULAR BIOMARKERS IN LETHAL PRIMARY PROSTATE CANCER
$1,169,017Regents Of The University Of Michigan · · FY2019 · Defense Health Agency
Cancer Immunotherapy Clinical Trials
$1,168,320Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,167,924Jane B Trepel · Clinical Sciences · Z01 · FY2007 · CA
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$1,167,374Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
MIRNA-RELATED POLYGENIC RISK SCORE AND MIRNA EXPRESSION ON PROSTATE CANCER SURVIVAL IN WHITES AND BLACKS
$1,167,053Louisiana State University Health Sciences Center New Orleans · · FY2025 · Defense Health Agency
TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS
$1,166,274Powell Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2021 · CA
LONG-READ DNA-SEQUENCING AND TARGETED RNA-SEQ TO IDENTIFY PREVIOUSLY UNDETECTABLE CLASSES OF MUTATIONS IN FAMILIES WITH LETHAL PROSTATE CANCER
$1,166,250University Of Washington · · FY2021 · Defense Health Agency
OPTIMIZING HIGH-DOSE TESTOSTERONE THERAPY FOR THE TREATMENT OF ADVANCED PROSTATE CANCER
$1,166,227The Regents Of The University Of Colorado · · FY2020 · Defense Health Agency
TARGETING RACIAL DISPARITIES IN STROMAL DGAT TO SUPPRESS AGGRESSIVE PROSTATE CANCER
$1,166,116Endeavor Health Clinical Operations · · FY2020 · Defense Health Agency
LUMINAL AND BASAL SUBTYPES AS BIOMARKERS IN PROSTATE CANCER
$1,165,340University Of Wisconsin System · · FY2020 · Defense Health Agency
TUMOR SUPPRESSOR RARRES1/TIG1 IN PROSTATE CANCER BIOMAKER TO THERAPEUTIC TARGET
$1,165,312Georgetown University · · FY2012 · Department of Defense
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program
$1,165,162Khalid Matin · Virginia Commonwealth University · UG1 · FY2021 · CA
Tissue Processing-Sequencing Facility
$1,164,770Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
$1,164,547Andrea Califano · Columbia University Health Sciences · U01 · FY2017 · CA
Study of hereditary prostate cancer and human artificial chromosomes
$1,164,537Vladimir Larionov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE
$1,164,524University Of North Carolina Chapel Hill · P01 · FY2001 · CA
TARGETING PROLIFERATING CELL NUCLEAR ANTIGEN FOR ENHANCING EFFICACY OF RADIOTHERAPY IN PROSTATE CANCER
$1,164,481Cincinnati Univ Of · · FY2022 · Defense Health Agency